An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 125156
Company: GENENTECH

Products on BLA 125156

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LUCENTIS	RANIBIZUMAB	10MG/ML	INJECTABLE; INJECTION	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 125156

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/30/2006	ORIG-1	Approval		N/A	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/125156lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/125156LTR.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/125156s0000_LucentisTOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/15/2024	SUPPL-128	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125156s128lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/125156Orig1s128ltr.pdf
03/20/2018	SUPPL-117	Supplement	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125156s117lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125156Orig1s117ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/125156Orig1s117.pdf
04/15/2017	SUPPL-114	Supplement	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125156s114lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/125156Orig1s114ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/125156Orig1s114.pdf
11/22/2016	SUPPL-112	Supplement	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125156s112lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/125156Orig1s112ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/125156Orig1s112.pdf
01/05/2017	SUPPL-111	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125156s111lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/125156Orig1s111ltr.pdf
10/13/2016	SUPPL-110	Supplement	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125156s110lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/125156Orig1s110ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/125156Orig1s110.pdf
02/06/2015	SUPPL-106	Supplement	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125156s106lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/125156Orig1s106ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125156Orig1s106.pdf
11/25/2014	SUPPL-105	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125156s105lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/125156Orig1s105ltr.pdf
02/27/2014	SUPPL-94	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125156s094lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/125156Orig1s094ltr.pdf
03/08/2013	SUPPL-87	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125156Orig1s087ltr.pdf
02/06/2013	SUPPL-81	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125156s081lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/125156Orig1s081ltr.pdf
08/10/2012	SUPPL-76	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125156s0069s0076lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/125156Orig1s0069,s0076ltr.pdf
08/10/2012	SUPPL-69	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125156s0069s0076lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/125156Orig1s0069,s0076ltr.pdf
06/22/2010	SUPPL-53	Supplement	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125156s053lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/125156s053ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/bla/2010/125156Orig1s053.pdf
05/19/2010	SUPPL-44	Supplement		Label is not available on this site.
04/23/2008	SUPPL-11	Supplement		Label is not available on this site.
04/26/2007	SUPPL-3	Supplement		Label is not available on this site.

Labels for BLA 125156

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/15/2024	SUPPL-128	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125156s128lbl.pdf
03/20/2018	SUPPL-117	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125156s117lbl.pdf
04/15/2017	SUPPL-114	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125156s114lbl.pdf
01/05/2017	SUPPL-111	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125156s111lbl.pdf
11/22/2016	SUPPL-112	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125156s112lbl.pdf
10/13/2016	SUPPL-110	Supplement	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125156s110lbl.pdf
02/06/2015	SUPPL-106	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125156s106lbl.pdf
11/25/2014	SUPPL-105	Efficacy	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125156s105lbl.pdf
02/27/2014	SUPPL-94	Efficacy	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125156s094lbl.pdf
02/06/2013	SUPPL-81	Efficacy	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125156s081lbl.pdf
08/10/2012	SUPPL-76	Efficacy	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125156s0069s0076lbl.pdf
08/10/2012	SUPPL-69	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125156s0069s0076lbl.pdf
06/22/2010	SUPPL-53	Efficacy	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125156s053lbl.pdf
06/30/2006	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/125156lbl.pdf

Top